Dawn Carter Bir Insider Trading $RETA REATA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dawn Carter Bir.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dawn Carter Bir. Dawn Carter Bir is Director in GERON CORP ($GERN) and Chief Commercial Officer in REATA PHARMACEUTICALS INC ($RETA) and VP, Chief Commercial Officer in REATA PHARMACEUTICALS INC ($RETA).
Dawn Carter Bir in REATA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dawn Carter Bir: VP, Chief Commercial Officer
Holdings: 60,000 shares
Current Value: $1,381,800
Latest Transaction: Nov 10 2020
$RETA Market Capitalization: $515.29M
$RETA Previous Close: $23.03
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Dawn Carter Bir in REATA PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | C | 0.00 | 60,000 | 0 | 0 | |
| Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | M | 0.00 | 60,000 | 0 | 60,000 | |
| Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | M | 21.05 | 60,000 | 1,263,000 | 90,000 | |
| Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Sell | S | 175.00 | 30,000 | 5,250,000 | 0 | 30 K to 0 (-100.00 %) |
| Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Sell | S | 150.01 | 30,000 | 4,500,300 | 30,000 | 60 K to 30 K (-50.00 %) |
| Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Buy | C | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | A | 207.20 | 24,000 | 4,972,800 | 24,000 | |
| Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | A | 55.73 | 17,250 | 961,343 | 17,250 | |
| Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | A | 55.73 | 17,250 | 961,343 | 17,250 | |
| Jan 03 2019 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | VP, Chief Commercia ... | Option Exercise | A | 55.73 | 34,500 | 1,922,685 | 34,500 | |
| Dec 07 2017 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | VP, Chief Commercia ... | Option Exercise | A | 24.75 | 71,300 | 1,764,675 | 71,300 | |
| Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | VP, Chief Commercia ... | Option Exercise | A | 22.57 | 40,000 | 902,800 | 40,000 |
Page: 1